Hongxia Xu
- Molecular Biology
- Cancer Research top 10%
- Hematology top 10%
- Electrical and Electronic Engineering
- Oncology
- Topics
- Multiple Myeloma Research and Treatments (5 papers)Protein Degradation and Inhibitors (4 papers)Computational Drug Discovery Methods (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hongxia Xu
25 papers receiving 647 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 374
- Cancer Research 190
- Hematology 97
- Electrical and Electronic Engineering 82
- Oncology 72
Countries citing papers authored by Hongxia Xu
This map shows the geographic impact of Hongxia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Xu more than expected).
Fields of papers citing papers by Hongxia Xu
This network shows the impact of papers produced by Hongxia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Xu. The network helps show where Hongxia Xu may publish in the future.
Co-authorship network of co-authors of Hongxia Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Xu. A scholar is included among the top collaborators of Hongxia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Xu. Hongxia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 7 | |
| 4 | 15 | |
| 5 | 1 | |
| 6 | 11 | |
| 7 | 60 | |
| 8 | 1 | |
| 9 | 11 | |
| 10 | 43 | |
| 11 | 106 | |
| 12 | 32 | |
| 13 | 10 | |
| 14 | 122 | |
| 15 | 20 | |
| 16 | 51 | |
| 17 | 73 | |
| 18 | 38 | |
| 19 | 17 | |
| 20 | 1 |
About Hongxia Xu
Hongxia Xu is a scholar working on Hematology, Cancer Research and Geriatrics and Gerontology, having authored 26 papers that have together received 653 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Cancer Research (190 citations), Hematology (97 citations) and Molecular Biology (374 citations). Hongxia Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huiying Han, Sha Song, Wenzhuo Zhuang, Bing-Zong Li, Chenao Qian, Wenqi Zhou, Lu Ouyang, Moli Huang, Xiaojuan Zhang and Nengjun Yi. Their work appears in journals such as Bioinformatics, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.